retatrutide studies (RETA) – Research Peptide Retatrutide 60mg | Premium 99%+

FDA prescribing information for EGRIFTA WR identifies tesamorelin as a therapy for reducing excess abdominal fat in adults with HIV-associated lipodystrophy and states that it is not indicated for weight-loss management

This includes not only the potential (though slow) degradation of the benzyl alcohol itself but also any potential interactions with the peptide you've reconstituted in the water

, ,

Instead, discard through a pharmacy take-back program or as instructed by the healthcare provider or pharmacist

Non-medication approaches also deserve consideration during your weight loss journey

Monitoring degradation behavior helps scientists predict shelf life and protect drug effectiveness